Antigen receptor repertoire profiling from RNA-seq data To the Editor: Somatic recombination and accumulation of mutations in V-D-J segments result in vast heterogeneity of T-cell receptor (TCR) and immunoglobulin repertoires 1, 2 . High-throughput profiling of immune receptors has become an important tool for studies of adaptive immunity and for the development of diagnostics, vaccines, and immunotherapies [3] [4] [5] [6] [7] . There are efficient molecular and software tools for the targeted sequencing of TCR and immunoglobulin repertoires 6, 8 , including MiXCR, developed by our team 9 . However, sufficient amount and quality of tissue or extracted RNA or DNA are not always available for analysis.
An alternative way of immune profiling is to use TCR and immunoglobulin transcripts that are present in bulk RNA-seq data. Because transcriptome sequencing has become routine in both basic and clinical studies, it could serve as a source of functionally relevant information on immune receptor hypervariable region (CDR3) repertoires. The massive repositories of RNA-seq data available from The Cancer Genome Atlas (TCGA, with >10,000 tumor samples; https://gdcportal.nci.nih.gov/) and other databases could be employed for immune repertoire profiling. Such analysis is of particular interest in cancer immunotherapy studies. Available tumor tissue is often limited, which precludes splitting the samples for separate transcriptome, TCR, and immunoglobulin profiling. Separate immune repertoire profiling also adds complexity and increases the costs for massive clinical studies. Furthermore, transcriptomic analysis is often employed in comparative studies of functional T-and B-cell subsets [10] [11] [12] , and it could additionally yield the immune receptor repertoires at no cost.
Several groups have reported tools for TCR or immunoglobulin repertoire extraction from bulk [13] [14] [15] [16] or single-cell 17 RNA-seq data. However, a broadly applicable software tool that enables the accurate and efficient extraction of immune repertoires from RNAseq was not available.
Here we develop a tool on the basis of MiXCR 9 , implementing a set of algorithms (Supplementary Methods, Supplementary Note 1, Supplementary Figs. 1 and 2 , and Supplementary Tables 1 and 2) to extract as many true CDR3 sequences as possible, with nearly zero CDR3-like false positives. The major advances in our approach include the following: 1) a sensitive and highly selective aligner that employs a fast algorithm but switches to a more sensitive modified Smith-Waterman/NeedlemanWunsch algorithm in ambiguous cases; 2) a partial alignments assembler that builds contigs from several initial alignments in a manner protected from artificial diversity generation (http://dx.doi.org/10.5281/ zenodo.804326); and 3) CDR3 extension (for TCRs but not immunoglobulins, because of the possible presence of hypermutations) that fills in the edges of the CDR3 based on known information on the relevant germline gene segments. The resulting RNA-seq analysis pipeline employs the same MiXCR modules, the same error-correction algorithms, and has the same output format as for targeted TCR or immunoglobulin profiling. This allows unified processing and comparison of immune repertoires obtained from different types of raw sequencing data.
Software testing with in silico-generated data demonstrated the high extraction efficiency of MiXCR, with zero false-positive clones observed. TRUST software 13, 16 efficiency was an order of magnitude lower, and the software generated a substantial number of false clonotypes (Supplementary Methods and Supplementary Fig. 3 ).
repertoires for IGH, IGK, IGL, TRA, and TRB chains from both melanoma samples, and outperformed both V'DJer and TRUST, yielding many-fold more canonical and minimal numbers of non-canonical clonotypes (Fig. 1d) . We additionally used several samples analyzed previously by others 13, 16 . In all comparisons, MiXCR demonstrated superior sensitivity, extracting 10-to 1,000-fold more clonotypes compared to V'DJer (Fig. 1e) . Both V'DJer and TRUST require substantially more hands-on time and application of third-party alignment tools with particular versions of the human genome and particular analysis settings, which are not clearly defined in the documentation and required optimization. The output from both tools irretrievably loses useful biological information (Supplementary Table 1 ). In of high-frequency clonotypes ( Fig. 1a and Supplementary Fig. 2 ). Most MiXCRreported clonotypes were confirmed by TCRseq data, while only a minor fraction of CDR3s reported by TRUST could be confirmed (Fig. 1b) . The clonotype frequencies extracted by MiXCR from RNA-seq data correlated with TCR-seq (Fig. 1c) , demonstrating that RNA-seq-based profiling can be quantitative for large clonotypes in samples that contain a substantial number of T cells.
We also compared MiXCR with V'DJer software 15 for the extraction of immunoglobulin repertoires. For some samples (including large SPX6730 and SPX8151 RNA-seq data sets) V'DJer failed to extract immunoglobulin heavychain (IGH) and light-chain (IGL, IGK) repertoires within 4 d using eight threads on a Xeon E5-2683 CPU with 50 GB of RAM. MiXCR successfully extracted To further verify the efficiency and specificity of extracting TCR CDR3 repertoires from RNA-seq data, we performed deep, targeted profiling of TCR alpha-(TRA) and beta-(TRB) chain repertoires (TCR-seq), as described 18 and 100+100-bp paired-end RNA-seq for the same RNA samples, obtained from surgically resected melanoma specimens from two patients, SPX6730 (ileocecal lymph node metastasis) and SPX8151 (small intestine resection).
We next assessed, estimated on the basis of TCR-seq data, the dependence of the number of TCR-seq-confirmed RNA-seq-extracted clonotypes on their abundance. MiXCR was able to extract all relatively large TRB-CDR3 clonotypes (frequency in repertoire >0.15%) from the lymph node metastasis RNA-seq, even with the short paired-end reads (trimmed in silico to 50+50 bp). In contrast, TRUST failed to extract a considerable proportion 
C O R R E S P O N D E N C E
germinal centers. Observation of extralarge immunoglobulin expansions and hypermutation processes in tumors raise the question of the antigenic specificity of dominant immunoglobulin variants, for which functional heavy-and light-chain pairs can be identified based on frequency 21 . If such dominant intratumorally produced immunoglobulins are tumor-specific 22 , exploration of their usefulness in precision immunotherapy-for example, in the context of chimeric antigen receptors (CARs 23 )-would be of considerable interest. We found that a high proportion of IgG1 of all IGH transcripts was associated with longer survival (Fig. 2d and Supplementary Fig. 4) , suggesting that intratumorally produced clonal single-cell T-cell transcriptome analysis, MiXCR outperformed TraCeR 17 in efficiency of TRA and TRB chain detection (Supplementary Table 3) .
Next, we extracted repertoires from TCGA 48+48-bp paired-end RNA-seq for 458 patients with cutaneous melanoma (SKCM) (see http://dx.doi.org/10.6084/ m9.figshare.4620739 for clone sets and Supplementary Note 2). Notably, the obtained immunoglobulin repertoires were an order of magnitude larger than the TCRs' , indicating the presence of intratumoral immunoglobulin-producing plasma cells.
High intratumoral IGH expression levels were associated with longer survival (Fig. 2a) , in agreement with recent work showing a positive correlation of activated B-cell gene signatures with survival in SKCM 19 . High levels of IGH clonality (analyzed as in ref . 20) were also associated with longer survival (Fig. 2b and Supplementary Fig. 4a) , and the two parameters had strong cumulative value. Patients with both high IGH expression and clonality had the best prognosis, whereas high IGH expression with low clonality was associated with poor prognosis (Fig. 2c) .
In many patients, a single dominant intratumoral immunoglobulin clonotype occupied 30-80% of all immunoglobulin CDR3 sequences in both heavy-and lightchain repertoires. Hypermutating IGH CDR3 variants could be observed even in primary tumor samples (Supplementary Table 4 and Supplementary Fig. 4b ), which could reflect the presence of intratumoral 1,000 2,000 3,000 4,000 5,000 0 1,000 2,000 3,000 4,000 5,000 0 1,000 2,000 3,000 4,000 5,000 0 1,000 2,000 3,000 4,000 5,000 0 1,000 2,000 3,000 4,000 5,000 Extracted repertoires were suitable for routine post-analysis using the VDJtools software 26 . To compare TCR diversity between these T-cell subsets, we normalized samples by extracting 500 random CDR3-containing reads, representing fragments of unique template RNA molecules from each sample. The correlation of the diversity between TRA and TRB chain repertoires was high (R > 0.95, Fig. 2e) , confirming the consistency of TRA and TRB repertoires extraction. Diversity was similar between T eff and T reg cells, and was significantly lower in CNS compared to spleen (P < 0.001, paired two-tailed Student's t-test, Fig. 2f) , reflecting the narrowed TCR repertoire in the CNS.
T reg cells were characterized by shorter TRB CDR3 lengths (Fig. 2g) . The functional characteristics of the amino acids comprising the middle portion of CDR3 differed between T reg and T eff cells TRB repertoires (Fig. 2h) . The higher affinity interaction (measured as a relative number of strongly interacting amino acids 27 ) of T reg CDR3s is in keeping with the previously observed higher TCR affinity of T regs for self-peptide-MHC (major histocompatibility) complexes, which may enable T reg precursors to compete more efficiently for the limited amount of antigen presented on thymic antigen-presenting cells [28] [29] [30] . Analysis of TRB-CDR3 amino acid repertoire overlaps revealed separate clustering of T eff and T reg cells. Co-clustering of the same T-cell subsets of multiple animals indicates their functional similarity across mice (Fig. 2i) . We conclude that detailed and highly informative insights into the structure of TCR repertoires can be obtained from RNA-seq data of sorted T-cell subsets.
RNA-seq analysis is rapidly becoming routine, both in clinical practice and basic research, with implementation gaining steam as the cost of high-throughput sequencing decreases and read-length increases. The MiXCR pipeline now enables straightforward mining of these data sets for immune repertoire profiling. We anticipate that in the near future RNA-seq-based profiling may replace targeted profiling of TCR and immunoglobulin repertoires in many applications.
The software, comprehensive user documentation, and source code can be found at https://github.com/milaboratory/mixcr. Our software is continuously upgraded, and the source code and stable binary releases are freely available for non-commercial use. Human, mouse and rat references are built in, and IMGT (http://www.imgt.org/) references can also be used for analysis. 
